Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AvePoint (AVPT) Operating Expenses: 2019-2025

Historic Operating Expenses for AvePoint (AVPT) over the last 6 years, with Sep 2025 value amounting to $73.5 million.

  • AvePoint's Operating Expenses rose 22.56% to $73.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $270.2 million, marking a year-over-year increase of 16.20%. This contributed to the annual value of $240.8 million for FY2024, which is 14.82% up from last year.
  • AvePoint's Operating Expenses amounted to $73.5 million in Q3 2025, which was up 7.32% from $68.4 million recorded in Q2 2025.
  • Over the past 5 years, AvePoint's Operating Expenses peaked at $73.5 million during Q3 2025, and registered a low of $34.0 million during Q1 2021.
  • Over the past 3 years, AvePoint's median Operating Expenses value was $59.9 million (recorded in 2024), while the average stood at $59.8 million.
  • As far as peak fluctuations go, AvePoint's Operating Expenses surged by 20,863.16% in 2021, and later fell by 21.25% in 2022.
  • Quarterly analysis of 5 years shows AvePoint's Operating Expenses stood at $46.2 million in 2021, then increased by 14.36% to $52.9 million in 2022, then grew by 2.39% to $54.1 million in 2023, then climbed by 15.30% to $62.4 million in 2024, then climbed by 22.56% to $73.5 million in 2025.
  • Its last three reported values are $73.5 million in Q3 2025, $68.4 million for Q2 2025, and $65.9 million during Q1 2025.